Biotech news today
The latest biotech and pharma news from the trade press, updated every hour and linked straight to the publisher. Follow funding, clinical, deals and more. Every story links straight to its publisher.
Regulatory B BioPharm International
FDA Clears IND for Biolojic’s BD200, the First AI-Designed Multibody ADC to Enter Clinical Trials
FDA has cleared Biolojic Design’s IND for BD200, a bispecific antibody-drug conjugate targeting Trop2 and Nectin-4 whose arms can each bind either target. A global Phase 1 study in solid tumors is expected to begin in the coming weeks.
Industry
European Biotechnology
Lakefront abandons Galapagos-developed TYK2 inhibitor after unsuccessful partnering efforts
Belgian biotech Lakefront Biotherapeutics, formerly Galapagos, has discontinued its oral TYK2 inhibitor GLPG3667 after analyzing the drug's competitive landscape and holding talks with potential partners. The autoimmune disease drug had met its primary endpoint in a Phase 2 derma…
Funding
PharmaVoice
How Nasdaq became biotech’s default exchange — and why the IPO comeback is testing its value
Nearly every U.S. biotech IPO lands on Nasdaq. As offerings rebound, the industry’s loyalty raises a harder question: What does the exchange actually deliver?
Industry
Pharmaceutical Technology
Blackstone backs Pfizer’s obesity ambitions with $1.5bn fund
Pfizer has an extensive clinical programme for berobenatide, acquired via its $10bn takeover of Metsera.
Industry P Pharmaceutical Executive
Moderna Lays Out Oncology-Driven Growth Plan at 2026 Analyst Day
Moderna used its 2026 Analyst Day to outline an oncology-driven growth strategy anchored by intismeran and other cancer antigen therapies.
Industry B BioPharm International
Blackstone to Provide Pfizer Up to $1.5 Billion for Monthly GLP-1 Berobenatide Development
Blackstone Life Sciences will fund up to $1.5 billion of development costs through 2028 for Pfizer’s monthly GLP-1 receptor agonist berobenatide, in exchange for milestone payments tied to approval and sales. Pfizer keeps full control of the program.
Agriculture
AgriBusiness Global
AgriBusiness Global on the Road: SICIT Group Dedicates New Plant in Leon, Mexico
The Italian-based biologicals manufacturer’s international expansion is the first step into targeting the Americas. The post AgriBusiness Global on the Road: SICIT Group Dedicates New Plant in Leon, Mexico appeared first on AgriBusiness Global.
Funding
MedTech Dive
J&J leads Francis Medical investment to fund prostate cancer device
With Johnson & Johnson’s support, Francis plans to take its water-vapor therapy device through the premarket approval process.
Industry B BioTechniques
BioTechniques holiday gift guide 2026
As the year draws to a close, nothing screams ‘winter’ quite like spending hours mulling over what to get your loved ones for the holidays. Well, yet again, we’d like to offer you a gift, too... in the form of our 2026 gift guide! Winter scenes and reads Wildlife Photographer of…
Regulatory B BioPharm International
FDA Grants Kamau RMAT Designation to Nula-cel for Sickle Cell Disease
Gene-corrected nula-cel freed all 3 RESTORE patients from transfusions, with sickle hemoglobin below 20% in the 2 followed for over 6 months.
Funding P Pharmaceutical Executive
Pfizer and Blackstone Sign Co-Funding Deal for berobenatide
Pfizer and Blackstone Life Sciences sign a co-funding deal in which Blackstone is set to provide up to $1.5 billion through 2028 to advance berobenatide.
Industry P Pharmaceutical Commerce
Pharma Pulse: Lilly and Hims & Hers Team Up, Swisslog Expands Tenutō Cold Storage
In this week’s Pharma Pulse, Lilly brings Zepbound and Foundayo to Hims & Hers, Swisslog Healthcare expands its Tenutō cold storage line, and FDA adds a NAION warning across the GLP-1 class.
Industry P PLOS Biology
Life-cycle plasticity enables conditional asexual reproduction in a kelp
by Daniel Liesner, Rémy Luthringer, Lineekela Kandjengo, John J. Bolton, Mark D. Rothman, Myriam Valero, Fabian B. Haas, Susana M. Coelho Many organisms alternate between distinct life stages and can reproduce either sexually or asexually, yet the mechanisms coordinating these de…
Industry P PLOS Biology
Category learning drives cortical attentional gain to diagnostic dimensions of perceptual information
by Sahil Luthra, Raha N. Razin, Adam T. Tierney, Lori L. Holt, Frederic Dick Humans and other animals develop remarkable perceptual and cognitive specializations for identifying, differentiating, and acting on classes of ecologically important signals. This expertise is flexible…
Industry P PLOS Biology
Neural integration of acoustic statistics enables mice to detect acoustic targets in noise
by Artoghrul Alishbayli, Karol Przewrocki, Paul van Heumen, Bernhard Englitz Sound detection amidst noise presents an important challenge in audition. Many naturally occurring sounds (rain, wind) can be described and predicted only statistically, so-called sound textures. Previou…
Industry P PLOS Biology
The importance of genes does not predict their mutation rate
by Sofia Radrizzani, Laurence D. Hurst The convention that mutation is a random process has been challenged by suggestions that selection has acted on between-gene variation in the mutation rate, with claims that more important genes are protected from mutation in part, in prokar…
Research E EMBL
Research project in Heidelberg-Heilbronn to advance precision medicine
EMBL, MOLIT, and the Dieter Schwarz Foundation join forces to accelerate the capacity of this field, using AI and cutting-edge technologies.
Industry S SecureBio
Longitudinal Tracking of BioTIER Performance
Model cards show how safeguards performed at launch but don’t show what happens afterwards. We're now running BioTIER regularly to track how refusal behavior changes after release.
Research
Pharmaceutical Technology
Beyond GLP-1RA’s: Novel mechanisms and combos to shape future of obesity market
Emerging mechanisms and combinatorial approaches are redefining the obesity space as the outcome focus shifts away from weight loss alone.
Industry P pharmaphorum
Are Makary's priority review vouchers about to be canned?
Are Makary's priority review vouchers about to be canned? Phil.Taylor Thu, 12/11/2026 - 12:16
Software
Pharmaceutical Technology
Podcast: Longevity, China, and AI the talk of the town at BIO Europe 2026
The attending members of the editorial team talk through the key themes and takeaways from the 2026 BIO-Europe conference.
Funding B BioTechniques
Europa Biosite acquires MEDISTA spol. s r.o.
Europa Biosite(Cambridge, UK) is pleased to announce the acquisition of MEDISTA spol. s r.o., a specialist distributor of diagnostics and laboratory technology in the Czech Republic. The acquisition is subject to customary regulatory approvals. The addition of MEDISTA marks anoth…
Industry
STAT Biotech
STAT+: Alnylam, once in the hunt to be a $100 billion biotech, needs to solve its heart drug problem
Alnylam is heavily dependent on its heart drug Amvuttra for growth — and sales have been slowing.
Clinical
STAT Biotech
STAT+: What to know about Biogen’s big lupus study readout
Biogen is expected to soon release the results of pivotal clinical trials of an experimental therapy for lupus.
Industry P pharmaphorum
NHS use of Incyte's anal cancer drug Zynyz backed by NICE
NHS use of Incyte's anal cancer drug Zynyz backed by NICE Phil.Taylor Thu, 12/11/2026 - 11:27
Industry
Clinical Trials Arena
Podcast: An emerging biotech’s guide to the CRO search
Centessa’s Scott Sawicki details how biotechs looking to transition to clinical work should look at CROs. The post Podcast: An emerging biotech’s guide to the CRO search appeared first on Clinical Trials Arena.
Clinical P Pharmaceutical Executive
How Patients’ Use of AI Impact How Sponsors Communicate with Them
With 60% of Americans using AI health tools, patient advocates are encouraging collaborative use of AI alongside healthcare teams for better outcomes.
Clinical A Applied Clinical Trials
ACT Brief: APAC Sponsor Priorities, Continuous Glucose Monitoring Trials, and GLP-1 Eye Warning
In today’s ACT Brief, we examine three priorities for first-time APAC sponsors, how continuous glucose monitoring should be used in diabetes trials, and why FDA is requiring a new eye-related warning across GLP-1 medications.
Funding
Clinical Trials Arena
Amgen’s acquired Sjögren’s drug a Phase III hit
Jefferies analysts say that, based on caveated cross-trial comparisons, dazodalipeb looks better efficacy-wise in Sjögren's than Novartis’ ianalumab. The post Amgen’s acquired Sjögren’s drug a Phase III hit appeared first on Clinical Trials Arena.
Industry P pharmaphorum
A certificate of analysis should be evidence, not a sales document
A certificate of analysis should be evidence, not a sales document Nicole.Raleigh Thu, 12/11/2026 - 10:37
Industry P pharmaphorum
Blackstone buys into Pfizer's GLP-1 drug development
Blackstone buys into Pfizer's GLP-1 drug development Phil.Taylor Thu, 12/11/2026 - 10:33
Regulatory
Pharmaceutical Technology
FDA and EMA waive paediatric studies for Shanton’s gout candidate
SAP-001 will not require paediatric studies in market authorisation applications for hyperuricemia and gout.
Clinical P pharmaphorum
From phase 1 to phase 3: Scaling radiopharmaceutical trials
From phase 1 to phase 3: Scaling radiopharmaceutical trials Nicole.Raleigh Thu, 12/11/2026 - 10:11
Clinical
Clinical Trials Arena
Patient enrolment begins in Actinium’s RADIANZ solid tumour trial
Actinium has begun patient enrolment in its RADIANZ trial, an imaging study supporting the Phase I therapeutic candidate ATNM-400 in advanced solid tumours. The post Patient enrolment begins in Actinium’s RADIANZ solid tumour trial appeared first on Clinical Trials Arena.
Industry
Pharmaceutical Technology
Life-extending peptides are likely not around the corner
Claims that peptides increase life span are still clinically inconclusive as experts await long-term mortality data.
Industry
Pharmaceutical Technology
Litmys and PharmaACE partner on pharma commercial forecasting
Litmys and PharmaACE have formed a strategic collaboration to provide commercial forecasting and decision-making services to the pharmaceutical and biotechnology sectors.
Industry
Pharmaceutical Technology
Building Annex 1 readiness into primary packaging
Packaging component design, manufacturing controls, and supplier evidence help pharmaceutical manufacturers strengthen contamination prevention from development through to sterile filling.
Industry P pharmaphorum
Lilly beats Novo to China with an oral GLP-1 for obesity
Lilly beats Novo to China with an oral GLP-1 for obesity Phil.Taylor Thu, 12/11/2026 - 09:28
Clinical
Clinical Trials Arena
Lilly reports promising 52-week results from TOGETHER-PsA trial in PsA
Lilly has reported promising 52-week results from the Phase IIIb TOGETHER-PsA trial assessing Taltz alongside Zepbound for active PsA in adults with overweight or obesity. The post Lilly reports promising 52-week results from TOGETHER-PsA trial in PsA appeared first on Clinical T…